Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study of Pomalidomide (Imnovid®) in Combination With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

NCT02075996 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT02075996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02075996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study of Pomalidomide (Imnovid®) in Combination With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Completed
Start date
February 11, 2014
Completion date
February 4, 2021
Enrollment
151 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma